Prospective Assessment of Symptoms and Quality of Life in Rectal Cancer Patients Receiving Chemo-Radiotherapy

Completed

Conditions studied: Rectal Cancer

In brief

Prospective Assessment of Symptoms and Quality of Life in Rectal Cancer Patients Receiving Chemo-Radiotherapy.

Key facts

Study ID

NCT00414232

Run by

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

People needed

13

Starts

2006-11-01

Expected to finish

2010-10-01

Last updated by the study team

2019-11-26

Who can join

Age: 18 and older, up to 100. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• All of the following questions must be answered "yes" for a patient to be eligible for this protocol.
• Is there a working diagnosis of rectal cancer? YES NO
• Will the patient be receiving neoadjuvant concurrent chemotherapy and pelvic radiation? YES NO
• Is the pelvic radiation planned for a dose of 45-54 Gy and will it be delivered using a standard 3-field technique? YES NO
• Is the patient ≥ 18 years of age? YES NO
• Can the patient give informed consent? YES NO

You may not qualify if…

• All of the following questions must be answered "no" for a patient to be eligible for this protocol.
• Has there been prior radiation to the pelvis? YES NO
• Is the patient in the "special category" designated by the Public Health Service (patients younger than 18, pregnant women, and prisoners)? YES NO

Where it is running

• The Sidney Kimmel Comprehensive Cancer Center at The Johns Hopkins University — Baltimore, Maryland, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.